Panpan Yu

Panpan Yu

Auto-generated profile, based on publicly available information

Panpan Yu

Guangdong-Hongkong-Macau Institute of CNS Regeneration; Ministry of Education Joint International Research Laboratory of CNS Regeneration, Jinan University, Guangzhou, Guangdong Province, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Trends in Neurosciences
Verified
Journal Article
Closed access
PYPanpan Yu
Panpan Yu
CPCraig S. Pearson
Craig S. Pearson
HGHerbert M. Geller
Herbert M. Geller

1 January 2018 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
PYPanpan Yu
Panpan Yu
JJJingyu Jin
Jingyu Jin
STSharada Tilve
Sharada Tilve
ZHZhonghai Huang
Zhonghai Huang
LZLibing Zhou
Libing Zhou
HGHerbert M Geller
Herbert M Geller
As one major component of extracellular matrix (ECM) in the central nervous system, chondroitin sulfate proteoglycans (CSPGs) have long been known as inhibitors enriched in the glial scar that prevent axon regeneration after injury. Although many studies have shown that CSPGs inhibited neurite outgrowth in vitro using different types of neurons, the mechanism by which CSPGs inhibit axonal growth remains poorly understood. Using cerebellar granule neuron (CGN) culture, in this study, we evaluated the effects of different concentrations of both immobilized and soluble CSPGs on neuronal growth, including cell adhesion, spreading and neurite growth. Neurite length decreased while CSPGs concentration arised, meanwhile, a decrease in cell density accompanied by an increase in cell aggregates formation was observed. Soluble CSPGs also showed an inhibition on neurite outgrowth, but it required a higher concentration to induce cell aggregates formation than coated CSPGs. We also found that growth cone size was significantly reduced on CSPGs and neuronal cell spreading was restrained by CSPGs, attributing to an inhibition on lamellipodial extension. The effect of CSPGs on neuron adhesion was further evidenced by interference reflection microscopy (IRM) which directly demonstrated that both CGNs and cerebral cortical neurons were more loosely adherent to a CSPG substrate. These data demonstrate that CSPGs have an effect on cell adhesion and spreading in addition to neurite outgrowth.

1 January 2015 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
XCXiaojian Cao
Xiaojian Cao
SFShiqing Feng
Shiqing Feng
CFChang-Feng Fu
Chang-Feng Fu
KGKai Gao
Kai Gao
JGJiasong Guo
Jiasong Guo
YZYu-Long Zhou
Yu-Long Zhou
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,China

1 October 2019 in Experimental Neurology
Verified
Journal Article
Closed access
ZHZhonghai Huang
Zhonghai Huang
JLJing Liu
Jing Liu
JJJingyu Jin
Jingyu Jin
QCQingpei Chen
Qingpei Chen
LSLisa B.E. Shields
Lisa B.E. Shields
PYPanpan Yu
Panpan Yu

23 April 2021 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
ZHZhong-Hai Huang
Zhong-Hai Huang
AFAi-Ying Feng
Ai-Ying Feng
JLJing Liu
Jing Liu
LZLibing Zhou
Libing Zhou
BZBing Zhou
Bing Zhou
PYPanpan Yu
Panpan Yu
Inhibitor of DNA binding 2 (Id2) can promote axonal regeneration after injury of the central nervous system. However, whether Id2 can promote axonal regeneration and functional recovery after peripheral nerve injury is currently unknown. In this study, we established a mouse model of bilateral sciatic nerve crush injury. Two weeks before injury, AAV9-Id2-3×Flag-GFP was injected stereotaxically into the bilateral ventral horn of lumbar spinal cord. Our results showed that Id2 was successfully delivered into spinal cord motor neurons projecting to the sciatic nerve, and the number of regenerated motor axons in the sciatic nerve distal to the crush site was increased at 2 weeks after injury, arriving at the tibial nerve and reinnervating a few endplates in the gastrocnemius muscle. By 1 month after injury, extensive neuromuscular reinnervation occurred. In addition, the amplitude of compound muscle action potentials of the gastrocnemius muscle was markedly recovered, and their latency was shortened. These findings suggest that Id2 can accelerate axonal regeneration, promote neuromuscular reinnervation, and enhance functional improvement following sciatic nerve injury. Therefore, elevating the level of Id2 in adult neurons may present a promising strategy for peripheral nerve repair following injury. The study was approved by the Experimental Animal Ethics Committee of Jinan University (approval No. 20160302003) on March 2, 2016.

16 September 2022 in Neural Regeneration Research
Verified
Journal Article
Open access
YXYa-Jie Xiong
Ya-Jie Xiong
SSShahid Hussain Soomro
Shahid Hussain Soomro
ZHZhong-Hai Huang
Zhong-Hai Huang
PYPan-Pan Yu
Pan-Pan Yu
JPJie Ping
Jie Ping
HFHui Fu
Hui Fu
JOURNAL/nrgr/04.03/01300535-202304000-00027/figure1/v/2026-05-25T155121Z/r/image-tiff The extracellular matrix surrounding oligodendrocytes plays an important role during myelination and remyelination in the brain. In many cases, the microenvironment surrounding demyelination lesions contains inhibitory molecules, which lead to repair failure. Accordingly, blocking the activity of these inhibitory factors in the extracellular matrix should lead to more successful remyelination. In the central nervous system, oligodendrocytes form the myelin sheath. We performed primary cell culture and found that a natural increase in fibronectin promoted the proliferation of oligodendrocyte progenitors during the initial stage of remyelination while inhibiting oligodendrocyte differentiation. Poly-L-ornithine blocked these inhibitory effects without compromising fibronectin’s pro-proliferation function. Experiments showed that poly-L-ornithine activated the Erk1/2 signaling pathway that is necessary in the early stages of differentiation, as well as PI3K signaling pathways that are needed in the mid-late stages. When poly-L-ornithine was tested in a lysolecithin-induced animal model of focal demyelination, it enhanced myelin regeneration and promoted motor function recovery. These findings suggest that poly-L-ornithine has the potential to be a treatment option for clinical myelin sheath injury.